Ingrid Pettersson

This inventor holds 30 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 10 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Novo Nordisk A/s, High Point Pharmaceuticals, LLC, Vtv Therapeutics LLC. Active years: 2001-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ingrid Pettersson. Retrieved from https://idiyas.com/inventor/ingrid-pettersson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 (Patent Applications = 5)

% Patents Active = 53.3

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 10 (Patent Applications = 4)

Average Co-Inventor Count = 5.0

ph-index = 12

Forward Citations = 269(Granted Patents)

Company Filing History:

High Point Pharmaceuticals, LLC

Years Active: 2001-2022

Loading Chart...

Areas of Expertise:

PPAR Delta Agonists

GLP-1 Derivatives

Insulin Analogues

Phenoxy Acetic Acids

Phenyl Propionic Acids

Combination Therapy

Aminoalkyl-Substituted Derivatives

Peroxisome Proliferator

Piperidine Derivatives

Substituted Imidazoles

Azetidines

Vinyl Carboxylic Acids

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11420929 - Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists (2022-08-23),

2. 11208452 - Insulins with polar recombinant extensions (2021-12-28),

3. 10919949 - Acylated insulin analogues and uses thereof (2021-02-16),

4. 10471066 - Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists (2019-11-12),

5. 10195255 - GLP-1 derivatives and uses thereof (2019-02-05),

6. 9855274 - Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists (2018-01-02),

7. 9663481 - Phenoxy acetic acids and phenyl propionic acids as PPARδ agonists (2017-05-30),

8. 9657079 - Truncated GLP-1 derivatives and their therapeutical use (2017-05-23),

9. 9409966 - Glucagon-like peptide-1 derivatives and their pharmaceutical use (2016-08-09),

10. 8895694 - Glucagon-Like Peptide-1 derivatives and their pharmaceutical use (2014-11-25),

11. 8551993 - Phenoxy acetic acids as PPAR delta activators (2013-10-08),

12. 8362016 - Phenyl propionic acids as PPAR delta activators (2013-01-29),

13. 7968723 - Compounds, their preparation and use (2011-06-28),

14. 7943613 - Compounds, their preparation and use (2011-05-17),

15. 7799924 - Substituted homopiperidine, piperidine or pyrrolidine derivatives (2010-09-21),

Title: **Ingrid Pettersson: Innovator in the Field of Biotechnology**

Introduction

Ingrid Pettersson, an accomplished inventor based in Frederiksberg, Denmark, has made significant contributions to the field of biotechnology. With a remarkable portfolio of 30 patents, her work primarily focuses on improving drug formulations and treatment methods for various medical conditions, particularly in diabetes care.

Latest Patents

Two of Ingrid's latest patents highlight her innovative approach to drug development. The first, titled "Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists," presents compounds that activate PPARδ, potentially beneficial for enhancing mitochondrial energy output and treating related conditions. The second patent, "Insulins with polar recombinant extensions," introduces novel insulin analogues featuring polar amino acid sequences designed to improve the drug's half-life and stability. This invention offers new pharmaceutical compositions for the treatment and prevention of diabetes-related medical conditions.

Career Highlights

Ingrid has held key positions at prominent companies in the pharmaceutical sector, including Novo Nordisk A/S and High Point Pharmaceuticals, LLC. These roles have allowed her to leverage her expertise in drug formulation and development, contributing to her success as an inventor.

Collaborations

Throughout her career, Ingrid has collaborated with notable professionals, including Per Sauerberg and John Patrick Mogensen. These partnerships have enriched her inventive process and provided opportunities for innovative research to flourish.

Conclusion

With a robust array of patents and a commitment to advancing biotechnology, Ingrid Pettersson stands out as a leading figure in her field. Her groundbreaking work not only enhances our understanding of drug efficacy and stability but also promises significant improvements in medical treatments for conditions such as diabetes.

Profile summary based on public USPTO records.